通过调控肿瘤代谢增强T细胞抗肿瘤活性

doi:10.11944/j.issn.1000-0518.2020.09.200164

摘要/Abstract

摘要： 肿瘤免疫治疗是一种新型的癌症治疗方法。然而,现阶段肿瘤免疫疗法的临床响应率低等问题严重制约了其进一步应用。其根本原因在于肿瘤组织免疫抑制微环境限制了T细胞的抗肿瘤活性,而肿瘤组织代谢改变在肿瘤免疫抑制微环境形成过程中起关键作用。本文重点总结了通过调控肿瘤的有氧糖酵解、氨基酸代谢和脂肪酸代谢增强T细胞的抗肿瘤活性。最后,提出当前肿瘤代谢调控研究方面仍然存在的问题,并对纳米载体在肿瘤代谢领域的发展前景进行了展望。

关键词: 肿瘤代谢, T细胞抗肿瘤活性, 有氧糖酵解, 氨基酸代谢, 脂肪酸代谢

Abstract: Tumor immunotherapy is a new technique for cancer treatment. However, the low clinical response rate of tumor immunotherapy at this stage seriously restricts its further application. The fundamental reason is that the immunosuppressive microenvironment of tumor tissue limits the antitumor activity of T cells, and the metabolic changes of tumor tissue play a key role in the formation of tumor immunosuppressive microenvironment. In this paper, we focus on enhancing the antitumor activity of T cells by regulating the aerobic glycolysis, amino acid metabolism and fatty acid metabolism of tumors. Finally, the current problems in the research of tumor metabolism regulation are proposed, and the development prospects of nanocarriers in the field of tumor metabolism are prospected.

Key words: tumor metabolism, T cell antitumor activity, aerobic glycolysis, amino acid metabolism, fatty acid metabolism

张思佳, 徐彩娜, 陈杰, 田华雨, 陈学思. 通过调控肿瘤代谢增强T细胞抗肿瘤活性[J]. 应用化学, 2020, 37(9): 977-984.

ZHANG Sijia, XU Caina, CHEN Jie, TIAN Huayu, CHEN Xuesi. Enhancing T Cell Antitumor Activity by Regulating Tumor Metabolism[J]. Chinese Journal of Applied Chemistry, 2020, 37(9): 977-984.

参考文献

[1] Petersen P E. Oral Cancer Prevention and Control-the Approach of the World Health Organization[J]. Oral Oncol,2009,45(4/5):454-460.
[2] Blagih J,Coulombe F,Vincent E E,et al. The Energy Sensor AMPK Regulates T Cell Metabolic Adaptation and Effector Responses in Vivo[J]. Immunity,2015,42(1):41-54.
[3] ZHANG Jidong,LI Jiayuan,JIN Huafeng. Research Progress on Small Molecule Anticancer Drug Release System Based on Fluorescence Effect[J]. Chinese J Appl Chem,2019,36(7):733-748(in Chinese).
张继东,李家源,金华峰. 基于荧光效应的小分子抗癌药物释放体系研究进展[J]. 应用化学,2019,36(7):733-748.
[4] WANG Yupeng,ZHOU Dongfang,CHENG Yanxiang,et al. Hemoglobin/Photosensitizer Compound Drug System for Photodynamic Therapy[J]. Chinese J Appl Chem,2018,35(12):1442-1448(in Chinese).
王玉鹏,周东方,程延祥,等. 血红蛋白/光敏剂复合药物体系用于光动力治疗[J]. 应用化学,2018,35(12):1442-1448.
[5] Dougan M,Dougan S K. Targeting Immunotherapy to the Tumor Microenvironment[J]. J Cell Biochem,2017,118:3049-3054.
[6] Palucka K,Banchereau J. Cancer Immunotherapy via Dendritic Cells[J]. Nat Rev Cancer,2012,12(4):265-277.
[7] McNutt M. Cancer Immunotherapy[J]. Science,2013,342(6165):1417.
[8] Schumacher T N,Schreiber R D. Neoantigens in Cancer Immunotherapy[J]. Science,2015,348(6230):69-74.
[9] Sharma P,Allison J P. The Future of Immune Checkpoint Therapy[J]. Science,2015,348(6230):56-61.
[10] Wu X,Giobbie-Hurder A,Liao X,et al. Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy[J]. Cancer Immunol Res,2017,5(1):17-28.
[11] Yarchoan M,Hopkins A, Jaffee E M. Tumor Mutational Burden and Response Rate to PD-1 Inhibition[J]. New Engl J Med,2017,377(25):2500-2501.
[12] Santarpia M,Karachaliou N. Tumor Immune Microenvironment Characterization and Response to Anti-PD-1 Therapy[J]. Cancer Biol Med,2015,12(2):74-78.
[13] Netea-Maier R T,Smit J W A,Netea M G. Metabolic Changes in Tumor Cells and Tumor-Associated Macrophages:A Mutual Relationship[J]. Cancer Lett,2018,413:102-109.
[14] Yu L,Chen X,Wang L,et al. The Sweet Trap in Tumors:Aerobic Glycolysis and Potential Targets for Therapy[J]. Oncotarget,2016,7(25):38908-38926.
[15] Warburg O,Wind F,Negelein E. The Metabolism of Tumors in the Body[J]. J Gen Physiol,1927,8:519-530.
[16] Gatenby R A,Gillies R J. Why do Cancers Have High Aerobic Glycolysis?[J]. Nat Rev Cancer,2004,4(11):891-899.
[17] Porporato P E,Payen V L,Baselet B,et al. Metabolic Changes Associated with Tumor Metastasis, Part 2:Mitochondria, Lipid and Amino Acid Metabolism[J]. Cell Mol Life Sci,2016,73(7):1349-1363.
[18] Currie E,Schulze A,Zechner R,et al. Cellular Fatty Acid Metabolism and Cancer[J]. Cell Metab,2013,18(2):153-161.
[19] Ho P C,Liu P S. Metabolic Communication in Tumors:A New Layer of Immunoregulation for Immune Evasion[J]. J Immunother Cancer,2016,4(1):4.
[20] Lunt S Y,Vander Heiden M G. Aerobic Glycolysis:Meeting the Metabolic Requirements of Cell Proliferation[J]. Annu Rev Cell Dev Bi,2011,27:441-464.
[21] Li Z,Zhang H. Reprogramming of Glucose, Fatty Acid and Amino Acid Metabolism for Cancer Progression[J]. Cell Mol Life Sci,2016,73(2):377-392.
[22] Ho P C,Bihuniak J D,Macintyre A N,et al. Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses[J]. Cell,2015,162(6):1217-1228.
[23] Yang B,Ding L,Chen Y,et al. Augmenting Tumor-Starvation Therapy by Cancer Cell Autophagy Inhibition[J]. Adv Sci,2020,7(6):1902847.
[24] Xie W,Deng W W,Zan M,et al. Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy[J]. ACS Nano,2019,13(3):2849-2857.
[25] Gao F,Cheng Q,Liu M D,et al. Local T Regulatory Cells Depletion by an Integrated Nanodrug System for Efficient Chem-Immunotherapy of Tumor[J]. Sci China Chem,2019,62(9):1230-1244.
[26] Jiang B. Aerobic Glycolysis and High Level of Lactate in Cancer Metabolism and Microenvironment[J]. Gene Dis,2017,4(1):25-27.
[27] Gao F,Tang Y,Liu W L,et al. Intra/Extracellular Lactic Acid Exhaustion for Synergistic Metabolic Therapy and Immunotherapy of Tumors[J]. Adv Mater,2019,31(51):1904639.
[28] Sukumar M,Liu J, Ji Y,et al. Inhibiting Glycolytic Metabolism Enhances CD8⁺ T Cell Memory and Antitumor Function[J]. J Clin Invest,2013,123(10):4479-4488.
[29] Labow B I,Souba W W. Glutamine[J]. World J Surg,2000,24(12):1503-1513.
[30] Shanware N P,Mullen A R,DeBerardinis R J,et al. Glutamine: Pleiotropic Roles in Tumor Growth and Stress Resistance[J]. J Mol Med,2011,89(3):229-236.
[31] Klysz D,Tai X G,Robert P A,et al. Glutamine-Dependent Alpha-Ketoglutarate Production Regulates the Balance Between T Helper 1 Cell and Regulatory T Cell Generation[J]. Sci Signal,2015,8(396):ra97.
[32] Nabe S,Yamada T,Suzuki J,et al. Reinforce the Antitumor Activity of CD8⁺ T Cells via Glutamine Restriction[J]. Cancer Sci,2018,109(12):3737-3750.
[33] Leone R D,Zhao L,Englert J M,et al. Glutamine Blockade Induces Divergent Metabolic Programs to Overcome Tumor Immune Evasion[J]. Science,2019,366(6468):1013-1021.
[34] Sukumar M,Liu J,Ji Y,et al. Inhibiting Glycolytic Metabolism Enhances CD8⁺ T Cell Memory and Antitumor Function[J]. J Clin Invest,2013,123(10):4479-4488.
[35] Greten T F,Manns M P,Korangy F. Myeloid Derived Suppressor Cells in Human Diseases[J]. Int Immunopharmacol,2011,11(7):802-807.
[36] Li X Y,Wenes M,Romero P,et al. Navigating Metabolic Pathways to Enhance Antitumor Immunity and Immunotherapy[J]. Nat Rev Clin Oncol,2019,16(7):425-441.
[37] Norian L A,Rodriguez P C,O'Mara L A,et al. Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8⁺ T Cell Function via L-Arginine Metabolism[J]. Cancer Res,2009,69(7):3086-3094.
[38] Brin E,Wu K,Lu H T,et al. PEGylated Arginine Deiminase can Modulate Tumor Immune Microenvironment by Affecting Immune Checkpoint Expression, Decreasing Regulatory T Cell Accumulation and Inducing Tumor T Cell Infiltration[J]. Oncotarget,2017,8:58948-58963.
[39] Geiger R,Rieckmann J C,Wolf T,et al. L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-Tumor Activity[J]. Cell,2016,167:829-842.
[40] Ron-Harel N,Santos D,Ghergurovich J M,et al. Mitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation[J]. Cell Metab,2016,24(1):104-117.
[41] Cheng C M,Geng F, Cheng X,et al. Lipid Metabolism Reprogramming and Its Potential Targets in Cancer[J]. Cancer Commun,2018,38(1):27.
[42] Monaco M E. Fatty Acid Metabolism in Breast Cancer Subtypes[J]. Oncotarget,2017,8(17):29487-29500.
[43] Liu Y. Fatty Acid Oxidation is a Dominant Bioenergetic Pathway in Prostate Cancer[J]. Prostate Cancer P D,2006,9(3):230-234.
[44] Clement E,Lazar I,Attan C,et al. Adipocyte Extracellular Vesicles Carry Enzymes and Fatty Acids that Stimulate Mitochondrial Metabolism and Remodeling in Tumor Cells[J]. EMBO J,2020,39(3):e102525.
[45] Pearce E L,Walsh M C,Cejas P J,et al. Enhancing CD8 T-Cell Memory by Modulating Fatty Acid Metabolism[J]. Nature,2009,460(7251):103-107.
[46] Pacella I,Procaccini C,Focaccetti C,et al. Fatty Acid Metabolism Complements Glycolysis in the Selective Regulatory T Cell Expansion During Tumor Growth[J]. P Natl Acad Sci USA,2018,115(28):E6546-E6555.
[47] Zhang Y,Kurupati R,Liu L,et al. Enhancing CD8⁺ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy[J]. Cancer Cell,2017,32:377-391.
[48] Zhang C,Yue C,Herrmann A,et al. STAT3 Activation-Induced Fatty Acid Oxidation in CD8⁺ T Effector Cells is Critical for Obesity-Promoted Breast Tumor Growth[J]. Cell Metab,2020,31(1):148-161.
[49] Xia J L,Tian H Y,Chen J,et al. Polyglutamic Acid Based Polyanionic Shielding System for Polycationic Gene Carriers[J]. Chinese J Polym Sci,2016,34(3):316-323.
[50] LIN Lin,GUO Zhaopei,CHEN Jie,et al. Synthesis and Characterization of Polyphenylalanine Grafted Low Molecular Weight PEI as Efficient Gene Carriers[J]. Acta Polym Sin,2017,2(2):321-328(in Chinese).
林琳,郭兆培,陈杰,等. 聚苯丙氨酸修饰低分子量聚乙烯亚胺制备高效基因载体[J]. 高分子学报,2017,2(2):321-328.
[51] Xu C N,Tian H Y,Wang Y B,et al. Anti-tumor Effects of Combined Doxorubicin and siRNA for Pulmonary Delivery[J]. Chinese Chem Lett,2017,28(4):807-812.
[52] Zhao H,Xu J,Li Y,et al. Nanoscale Coordination Polymer Based Nanovaccine for Tumor Immunotherapy[J]. ACS Nano,2019,13(11):13127-13135.